ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 27 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | 0.0% | 9,751 | -6.0% | 0.00% | – |
| Q1 2017 | $4,000 | -20.0% | 10,376 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | 0.0% | 10,376 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -54.5% | 10,376 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | +57.1% | 10,376 | -0.6% | 0.00% | – |
| Q1 2016 | $7,000 | -46.2% | 10,435 | +0.6% | 0.00% | – |
| Q4 2015 | $13,000 | -43.5% | 10,376 | -0.8% | 0.00% | – |
| Q3 2015 | $23,000 | -4.2% | 10,459 | +0.3% | 0.00% | – |
| Q2 2015 | $24,000 | +9.1% | 10,424 | +0.5% | 0.00% | – |
| Q1 2015 | $22,000 | -8.3% | 10,376 | -3.2% | 0.00% | – |
| Q4 2014 | $24,000 | -22.6% | 10,719 | -5.7% | 0.00% | – |
| Q3 2014 | $31,000 | -38.0% | 11,370 | -17.2% | 0.00% | – |
| Q2 2014 | $50,000 | -66.4% | 13,732 | +7.9% | 0.00% | – |
| Q1 2014 | $149,000 | +24.2% | 12,731 | -11.4% | 0.00% | – |
| Q4 2013 | $120,000 | +31.9% | 14,377 | +47.1% | 0.00% | – |
| Q3 2013 | $91,000 | -5.2% | 9,771 | +0.0% | 0.00% | – |
| Q2 2013 | $96,000 | – | 9,770 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|